Trial Profile
Pharmacokinetics of Ertapenem Following Subcutaneous or Intravenous Infusion in Patients Aged Over 75 (PHACINERTA)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Nov 2019
Price :
$35
*
At a glance
- Drugs Ertapenem (Primary) ; Ertapenem (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- Acronyms PHACINERTA
- 01 Dec 2019 Results reporting and comparing ertapenem pharmacokinetic data between IV and SC routes in older persons published in the Journal of Antimicrobial Chemotherapy
- 24 Apr 2018 Results presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases
- 14 Sep 2016 Status changed from recruiting to completed.